Proteinea

Rewiring immune function with precision engineered antibodies

Cambridge, Egypt · Founded 2020 · $250K raised

Headquarters
Cambridge
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$250K
Last Round
$250K SeedMar 2021
Rounds
1

About

Proteinea is a TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. The company specializes in rational engineering of antibody Fc domains to enable context-specific immune tuning, enhanced half-life, and targeted biodistribution, combining AI-driven prediction with therapeutic insight. Proteinea's proprietary AI models and computational tools engineer next-generation antibodies with improved efficacy, safety, and manufacturability, with operations in Cambridge MA, Cairo, KAUST, and Munich.

Summary

Proteinea is a Biotech company based in Cambridge, Egypt, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Mar 2021. Investors include IndieBio.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2021
$250K

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Proteinea on Indexed.vc
<a href="https://indexed.vc/companies/proteinea"><img src="https://indexed.vc/api/badge/company/proteinea" alt="Proteinea on Indexed.vc" width="260" height="76" /></a>